Position in BHC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$123,915
-$268,724 QoQ
Shares Held
25,135
-65.4% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#140
of 220 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Derivatives in BHC
reported options exposure · as of Sep 30, 2022CallValue
$1,722,500
CallShares
250,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $845,206,958 across 34 Drug Manufacturers - Specialty & Generic names. BHC ranks #31 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
340,275 | $184,371,197 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
3,316,358 | $136,070,166 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
553,068 | $93,214,076 | |
| 4 | VTRS |
Viatris Inc
|
5,658,439 | $89,856,006 | |
| 5 | ZTS |
Zoetis Inc.
|
912,367 | $65,562,688 | |
| 6 | ALKS |
Alkermes plc.
|
1,170,242 | $61,320,679 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
2,950,225 | $52,986,040 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
2,844,583 | $41,218,006 |
All Filings in BHC
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $123,915 | 25,135 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $392,639 | 72,711 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $483,240 | 69,531 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $468,224 | 72,593 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,447,384 | 1,118,226 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $27,984,398 | 4,325,255 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $42,853,584 | 5,316,822 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $42,924,667 | 5,260,376 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $79,447,871 | 11,398,547 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $168,181,040 | 15,851,182 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $126,726,768 | 15,801,343 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $129,887,959 | 15,801,455 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $132,596,224 | 16,574,528 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $134,493,289 | 16,604,110 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $111,055,926 | 17,684,065 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $1,722,500 | 250,000 | Call | Defined | 2022-11-14 | |
| 2022-09-30 | $128,110,790 | 18,593,729 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $61,558,064 | 7,363,405 | Shares | Defined | 2022-08-11 | |
| 2022-06-30 | $2,090,000 | 250,000 | Call | Defined | 2022-08-11 | |
| 2022-03-31 | $3,531,764 | 154,563 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $5,812,262 | 210,513 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $5,810,176 | 208,624 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $5,495,856 | 187,444 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $5,512,792 | 173,686 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,112,738 | 101,574 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $1,521,318 | 97,897 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,817,202 | 99,355 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $2,772,981 | 178,902 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||